NB

Nupendra Bisen

Active Director Director DIN 10856822
DIN 10856822 First appointment Nov 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nupendra Bisen

Data last updated:

Nupendra Bisen is a Director at Nutriheed Healthcare Private Limited (since 2024).

DIN 10856822
Primary Designation Director
First Appointment 30 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nutriheed Healthcare Private Limited U46497MH2024PTC435835
Director30 Nov 20242024Active

Board colleagues of Nupendra Bisen

NameDINCompanyDesignation
Mahendra Hanwat10287213Nutriheed Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nutriheed Healthcare Private Limited
Premium access

Shareholding and investment profile for Nupendra Bisen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nupendra Bisen

Nupendra Bisen currently holds 1 directorship: Nutriheed Healthcare Private Limited (Director, since 30 Nov 2024).

Nupendra Bisen was first appointed on 30 Nov 2024 as Director at Nutriheed Healthcare Private Limited.

The current boards of Nupendra Bisen's companies include Mahendra Hanwat (Nutriheed Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available